INTRODUCTION
Lysophosphatidic acid (LPA ; 1-acyl-sn-glycerol-3-phosphate), in addition to playing a role in the de no o synthesis of phospholipids, demonstrates many properties of an extracellular signalling molecule [1] [2] [3] . LPA elicits a wide range of biological effects, including inhibition of adenylate cyclase, activation of phosphoinositide-specific phospholipase C (PLC), mobilization of intracellular Ca# + stores, cell proliferation, neurite retraction and neurotransmitter release [4] [5] [6] [7] [8] [9] [10] . Radioligand binding studies [9, 11] and molecular cloning [12] [13] [14] [15] [16] suggest that most of these actions of LPA are likely to be receptor-mediated.
Many studies have now demonstrated the ability of LPA to stimulate increases in intracellular free Ca# + levels ([Ca# + ] i ) [4, 6, 7, 11, [17] [18] [19] [20] [21] , predominantly via the mobilization of Ca# + stores. Similar to other agents acting through G-protein-coupled receptors (GPCRs) (see [22] ), this action of LPA can occur through the production of the second messenger, Ins(1,4,5)P $ . Indeed, LPA stimulates InsP production in numerous cell types [4, 6, 11, 18, 20] , and the Ca# + response can be inhibited by the PLC inhibitor U73122 [6, 19] . However, in many of the reports it is unclear which LPA receptor subtype is involved in the Ca# + -Abbreviations used : [Ca 2 + ] i , intracellular Ca 2 + concentration ; CLB, cytosol-like buffer ; NAS, N-acetylsphingosine ; dihydro-NAS, dihydro-Nacetylsphingosine ; DMS, N,N-dimethylsphingosine ; FAF-BSA, fatty acid-free BSA ; fura-2/AM, fura-2 acetoxymethyl ester ; GDP [S] , guanosine 5h-[γ-thio]-diphosphate ; GPCR, G-protein-coupled receptor ; InsP 3 R, Ins(1,4,5)P 3 receptor ; KHB, Krebs-Henseleit buffer ; LPA, lysophosphatidic acid (1-acylsn-glycerol-3-phosphate) ; MCh, methacholine ; PLC, phosphoinositide-specific phospholipase C ; PTX, pertussis toxin ; RyR, ryanodine receptor ; SPP, sphingosine 1-phosphate. 1 To whom correspondence should be addressed (e-mail kwy1!le.ac.uk). 2 Present address : Department of Biochemistry, University College Cork, National University of Ireland, Lee Maltings Complex, Prospect Row, Cork, Ireland.
cells in response to MCh or exogenously added Ins(1,4,5)P $ , but failed to inhibit Ca# + -release induced by LPA. Elevation of [Ca# + ] i elicited by LPA was blocked by guanosine 5h-[β-thio]-diphosphate, indicating that this agonist acts via a G-proteincoupled receptor. However, pertussis toxin was without effect on LPA-evoked [Ca# + ] i responses, suggesting that G i/o -proteins were not involved. In the absence of extracellular Ca# + , N,N-dimethylsphingosine (DMS, 30 µM), a competitive inhibitor of sphingosine kinase, blocked LPA-induced Ca# + responses by almost 90 %. In addition, MCh-induced Ca# + responses were also diminished by the addition of DMS, although to a lesser extent than with LPA. We conclude that LPA mobilizes intracellular Ca# + -stores in SH-SY5Y cells independently of the generation and action of Ins(1,4,5)P $ . Furthermore, the Ca# + -response to LPA appears to be dependent on sphingosine kinase activation and the potential generation of the putative second messenger sphingosine 1-phosphate.
Key words : Ca# + -signalling, dimethylsphingosine, heparin. mobilizing response and also which G-protein is responsible for transducing the signal. Recently, Edg-2 and Edg-4 (putative GPCRs for LPA [14, 15] ) have been recombinantly expressed in cultured mammalian cells [21] , the stimulation of which leads to InsP production and Ca# + mobilization with both subtypes. The Edg-2-mediated response is abolished by pretreatment with pertussis toxin (PTX) or U73122, indicating that Ins(1,4,5)P $ production is through PLC activation, most likely via βγ-subunits of G i -proteins. In contrast, the Edg-4 response is only partially inhibited by PTX (but is still abolished by U73122), suggesting the additional involvement of G q -proteins [21] . However, it should be noted that not all the actions of LPA on [Ca# + ] i are via Ins(1,4,5)P $ production. Thus, in Jurkat T cells, LPA does not stimulate Ins(1,4,5)P $ production, and Ca# + mobilization is not from an Ins(1,4,5)P $ -sensitive store [7] . Therefore, the possibility remains for the existence of other LPA receptors with potentially novel signalling mechanisms.
In the present study we have investigated LPA-induced Ca# + signalling in human SH-SY5Y neuroblastoma cells. We report that in SH-SY5Y cells, activation of an endogenous LPA receptor leads to Ca# + mobilization, independent of the phosphoinositide signalling pathway, but dependent on the action of sphingosine kinase, and thus represents a novel signalling pathway for LPA. Comparisons with an established Ins(1,4,5)P $ -mediated, Ca# + -mobilizing receptor system have been made using methacholine (MCh) to stimulate endogenous muscarinic M $ -receptors in SH-SY5Y cells.
EXPERIMENTAL Materials
ATP, anti-rabbit IgG antiserum-horseradish peroxidase conjugate, β-escin, EGTA, fatty acid-free BSA (FAF-BSA), ionomycin, low-molecular-mass heparin (4-6 kDa), LPA (1-oleoyl-snglycerol-3-phosphate), PTX and phosphatidic acid (1,2-diacylsn-glycerol-3-phosphate) were from Sigma. Fura-2 acetoxymethyl ester (fura-2\AM), fura-2 free-acid and fluo-3 free-acid were from Molecular Probes. 
Cell culture
SH-SY5Y neuroblastoma cells (passage 70-90) were grown in minimal essential medium with Earle's salts, 10 % (v\v) fetal calf serum, 2 mM -glutamine, 2.5 µg\ml fungizone, 100 units\ml penicillin and 100 µg\ml streptomycin at 37 mC in a humidified atmosphere of 5 % CO # \95 % air.
Measurement of Ins(1,4,5)P 3 mass and total [ 3 H]inositol phosphates
SH-SY5Y neuroblastoma cells were grown to confluency on 24-well plates. Incubations were performed in Krebs-Henseleit buffer (KHB : 120 mM NaCl\4.8 mM KCl\1.2 mM MgSO % \ 2 mM CaCl # \1.2 mM KH # PO % \25 mM NaHCO $ \5 mM Hepes, pH 7.2) at 37 mC. For measurement of total inositol phosphates, cells were pretreated with KHB supplemented with 10 mM LiCl for 10 min to block inositol monophosphatase activity. Cellular Ins(1,4,5)P $ mass and total InsP levels were then determined as previously described [23] .
Measurement of [Ca 2 + ] i in cell suspensions
Confluent monolayers of SH-SY5Y neuroblastoma cells grown in 175 cm# flasks were harvested by incubation in 0.9 % (w\v) NaCl, 0.02 % (w\v) EGTA and 10 mM Hepes, pH 7.2. Cells were washed twice with KHB, resuspended to a density of approx. 1i10' cells\ml, and then incubated with 3 µM fura-2\AM for 45 min at room temperature. Aliquots (" 0.5i10' cells) of this suspension were washed once, then resuspended in 2 ml of KHB in a stirred fluorimetry cuvette at 37 mC. Fluorescence was measured with a Perkin-Elmer LS-50B luminescence spectrometer (alternate excitation wavelengths of 340 nm and 380 nm ; emission wavelength, 505 nm). At the end of each experiment, R max (the maximum ratio of emission intensities after excitation at 340 and 380 nm) was determined by the addition of 0.1 % Triton X-100, then R min was estimated using 4 mM EGTA. Autofluorescence values, determined in parallel experiments using an aliquot of each cell suspension ] buffered to 100-200 nM using EGTA) containing 1 µM fluo-3-free acid in a stirred cuvette at 37 mC. Each experimental condition was examined in series using CLB containing the same amount of EGTA. Fluorescence intensities were measured continuously using a Perkin-Elmer LS-50B luminescence spectrometer with an excitation wavelength of 505 nm and an emission wavelength of 530 nm. Cells were treated with 25 µg\ml β-escin, resulting in more than 95 % of cells becoming permeabilized, as assessed by failure to exclude Trypan Blue. An ATP-regenerating system, consisting of 5 units\ml creatine kinase and 10 mM phosphocreatine, was added directly to the cuvette. Once a stable baseline was attained, test substances were added at appropriate time points, followed by 5 µM ionomycin, then 2 mM CaCl # and 0.1 % Triton X-100 to estimate the maximum fluorescence, F max , and finally 4 mM EGTA to measure F min . Further addition of EGTA did not lower [Ca# + ] i , suggesting that F min had been achieved.
Single-cell Ca
2 + imaging SH-SY5Y cells, grown on 22-mm diam. coverslips (Chance Propper Ltd., Warley, West Midlands, U.K.) were incubated in KHB supplemented with 8 µM fura-2 for 60 min at 22 mC before being mounted on the stage of a Nikon Diaphot inverted epifluorescene microscope and heated to 37 mC. Agonists were added directly to the perfusion chamber. Images at wavelengths above 510 nm were collected, after excitation at 340 and 380 nm, with an intensified charge-coupled device camera (Photonic Science) using a Quanticell 700 (Applied Imaging) system. Ratiometric values were converted into approximate [Ca# + ] i as described previously [25] . For experiments concerning the actions of DMS, SH-SY5Y cells were grown to a confluent monolayer on 22 mm coverslips and imaged as described above. Cells were preincubated in KHB to which no Ca# + had been added plus inhibitors (where appropriate) for 10 min before agonist addition. Each condition was directly compared with control responses measured in parallel.
Quenching of fura-2 fluorescence with Mn 2 +
SH-SY5Y cells, prepared as described above, were pretreated with 250 µM Mn# + in Ca# + -free Hepes buffer (120 mM NaCl, 5.4 mM KCl, 1.8 mM CaCl # , 1.6 mM MgCl # , 25 mM Hepes and 11 mM -glucose) for 100 s before addition of agonists in the same buffer. Experiments were conducted at room temperature (" 22 mC). Fluorescent emissions above 510 nm after excitation at 360 nm (the isosbestic point of fura-2) were measured on a photomultiplier system (Photon Technology International, Surbiton, U.K.). The rate of quenching of fura-2 fluorescence by Mn# + was calculated by a best-fit monoexponential using GraphPad Prism software.
Preparation of cell membranes and immunoblotting
These techniques were performed as described previously [26] . A 1 : 1000 dilution of polyclonal antiserum CT-1, raised against a synthetic peptide corresponding to the C-terminal 19 amino acid residues of the type 1 InsP $ receptor (InsP $ R), was used to assess the density of this protein in membranes prepared from vehicle-, MCh-and MCh plus atropine-stimulated cells. Figure 1A ). This increase in [Ca# + ] i was followed by a return to near resting levels within 3 min of addition. Supramaximal doses of MCh (1 mM) resulted in a peak [Ca# + ] i of similar magnitude (576p35 nM above resting levels, n l 4) to that triggered by LPA, although with MCh there was a pro- Figure 1B) . Treatment of SH-SY5Y cell suspensions with the sarcoplasmic\endoplasmic-reticulum Ca# + -ATPase pump inhibitor thapsigargin (500 nM) resulted in a slow increase in [Ca# + ] i , followed by a sustained plateau. Supramaximal doses of LPA (10 µM) or MCh (1 mM) failed to elevate [Ca# + ] i above this thapsigargin-induced plateau, indicating that their effects are dependent on Ca# + mobilization from these intracellular stores (results not shown).
RESULTS

LPA and MCh elevate [Ca
Effect of LPA and MCh on InsP production in SH-SY5Y cells
A supramaximal dose of MCh (1 mM) elicited a biphasic increase in Ins(1,4,5)P $ mass levels in SH-SY5Y cells, with a peak at 20 s followed by a sustained plateau (Figure 2) . In contrast, a supramaximal dose of LPA (10 µM) failed to increase Ins(1,4,5)P $ mass above basal levels ( Figure 2 ). This lack of detectable Ins(1,4,5)P $ accumulation was not a consequence of LPA interfering with the mass assay employed, since responses to MCh in the additional presence of LPA were indistinguishable from those to MCh alone ( Figure 2 
Effect of GDP[S] and heparin on Ca 2 + -mobilization in permeabilized SH-SY5Y cells
In β-escin-permeabilized cells, Ca# + signalling mediated by MCh or LPA, monitored using fluo-3, was well maintained. In control experiments, a supramaximal dose of LPA (10 µM) elevated [Ca# + ] i from a resting level of 142p8 nM to 458p27 nM, which gradually returned to near resting levels (n l 5) ( Figure 4A 100 µg\ml of low-molecular-mass heparin for 5 min resulted in a small decrease in resting [Ca# + ] i , to 115p10 nM (n l 4). Heparin pre-treatment dramatically inhibited the Ca# + responses of these cells to MCh (168p19 nM, P 0.001 compared with control) and to Ins(1,4,5)P $ (189p17 nM, P 0.001) ( Figure 4C ). However, [Ca# + ] i elevation caused by LPA was not significantly altered in the presence of heparin (366p55 nM, P 0.05 versus control).
Effect of signalling-pathway inhibitors on LPA-stimulated Ca 2 + -mobilization
The results described so far indicate that LPA-induced increases in [Ca# + ] i do not involve either Ins(1,4,5)P $ production or the InsP $ R. Therefore, the effects of a number of pharmacological inhibitors of various signalling pathways on LPA-stimulated Ca# + mobilization were investigated in an attempt to determine the mechanism involved. As can be seen from Table 1 , LPAstimulated increases in [Ca# + ] i were unaffected by pretreatment with PTX (100 ng\ml, 18 h), ryanodine (10 µM, 30 min), procaine (1 mM, 5 min) and N ω -nitro--arginine (50 µM, 60 min). The LPA response was also unaffected by pretreatment with the protein kinase inhibitors bisindoylmaleimide (100 nM, 5 min), H-89 (10 µM, 5 min) or genistein (100 µM, 5 min). However, the peak [Ca# + ] i response to 10 µM LPA was reduced by 55p5 % by a 5 min pretreatment with 1 µM phorbol 12,13-dibutyrate (1 µM, 5 min) (n l 3).
LPA and MCh stimulate Ca 2 + -entry into fura-2-loaded SH-SY5Y cells
As LPA appears to mobilize Ca# + via a novel pathway, the ability of the LPA-accessible Ca# + pool to stimulate store-refillingmediated Ca# + entry was investigated. This was especially important as previous work, in Jurkat human T-cells, reported that LPA-stimulated Ca# + mobilization does not activate Ca# + entry [7] . To determine Ca# + -entry into SH-SY5Y cells, Ca# + in the Hepes buffer was substituted with 250 µM Mn# + , and the rate of Mn# + entry was measured by the ability of this ion to quench fura-2 fluorescence. Application of 250 µM Mn# + itself caused a time-dependent decrease in fura-2 fluorescence, which approximated to a monoexponential decay curve with a rate constant of 0.18 (p0.01)i10 −% s −" (n l 3). This rate increased to 4.32 (p0.09)i10 −% s −" when the cells were stimulated with 10 µM LPA (n l 3) ( Figure 5 ). In comparison, MCh (100 µM) increased the rate of quench to 10.13 (p0.06)i10 −% s −" (n l 3) ( Figure 5 ).
LPA-and MCh-stimulated Ca 2 + mobilization in single SH-SY5Y cells
To examine spatiotemporal aspects of the LPA-stimulated Ca# + release pathway, single, fura-2-loaded SH-SY5Y cells were fluorescently imaged. In this set of experiments, LPA (10 µM, 
Effect of DMS on LPA-, MCh-and ionomycin-stimulated Ca 2 + mobilization in SH-SY5Y cells
As LPA-induced Ca# + mobilization did not appear to involve either of the well-characterized pathways of release, we investigated the potential role of sphingosine kinase in SH-SY5Y cells. Previous work has described the ability of SPP, produced from sphingosine via sphingosine kinase in response to activation of GPCRs, to stimulate Ca# + release from intracellular stores [29] . In order to minimize the effects of the sphingosine kinase inhibitor DMS on Ca# + entry [30] , experiments were performed in nominally Ca# + -free KHB (see Experimental section). Pretreatment of SH-SY5Y cells with 30 µM DMS for 10 min slightly increased basal [Ca# + ] i from 62p2 nM to 70p2 nM (n l 9), and reduced the peak Ca# + response to 1 µM LPA by 88p4 % (P 0.05, unpaired t-test ; n l 3) (Figures 6A and 6B) . A similar degree of inhibition block was observed if total Ca# + release, calculated as the area under the curve, was measured (87p4 % inhibition). Preincubation with 30 µM DMS also reduced the Ca# + response to 1 mM MCh (57p11 % reduction in peak and 41p12 % reduction in total Ca# + release ; P 0.05, n l 3) ( Figures 6D and 6E ). In contrast, preincubation with either 30 µM NAS ( Figures 6C and 6F ), or the bio-inactive dihydro-NAS (results not shown), compounds which do not inhibit sphingosine kinase, did not block the Ca# + responses to LPA or MCh (n l 3). DMS (30 µM) also reduced the peak Ca# + response to the addition of 2 µM ionomycin by 27p11 % (n l 3) ( Figures  6G and 6H ). However, this was not significantly different from the control values, and if the action of DMS was measured on total Ca# + release no effect was observed (2p14 % decrease).
DISCUSSION
There is growing evidence in the literature that LPA, and structural analogues such as SPP, represent a novel family of signalling molecules which are responsible for a diverse array of cellular responses [3] . The search for the cell-surface receptors responsible for initiating the intracellular responses to these signalling molecules has led to the discovery of Edg-2 and Edg-4, putative GPCRs for LPA [14, 15] , and Edg-1, a putative GPCR for SPP [31] . However, it is currently unclear which of the cloned receptor types are responsible for the multiple cellular responses observed in the various cell types, and it seems probable that more LPA receptors remain to be discovered. In the present study, investigating the effects of LPA on Ca# + signalling in human SY-SY5Y neuroblastoma cells, we have obtained evidence for an LPA receptor which is mechanistically distinct from those reported in many other cell types. [33] , which demonstrated that in SH-SY5Y cells, LPA-receptor activation failed to stimulate G q/"" α activity, whereas M3 muscarinic receptor activation produced a robust response (K. W. Young and S. R. Nahorski, unpublished work).
These observations indicate that, unlike the cloned Edg-2 and Edg-4 receptors, the LPA receptor in SH-SY5Y cells does not utilize the phosphoinositide signalling pathway. In skeletal and cardiac muscles, the predominant mechanism of Ca# + release from intracellular stores is via the ryanodine receptor (RyR) [34] . RyRs are present throughout the mammalian nervous system [34] , and ryanodine-sensitive Ca# + pools coupled to extracellular stimuli have been characterized in a number of mammalian celllines, including HeLa [35] , PC-12 [36] and SK-N-BE [37] cells. Furthermore, the presence of both the type 2 (cardiac type) RyR protein and Ca# + pools sensitive to caffeine, an agonist of these channels, in SH-SY5Y cells have been demonstrated recently [27] . However, LPA does not appear to activate RyRs in SH-SY5Y cells, as Ca# + mobilization was unaffected by ryanodine itself, or the RyR-antagonist procaine. Modulation of ryanodinesensitive Ca# + stores by the nitric oxide\cGMP pathway, via cADP-ribose, has recently been characterized in neurosecretory PC-12 cells [38] . However, LPA-induced Ca# + mobilization was unaffected by N ω -nitro--arginine, a nitric oxide synthase inhibitor. Interestingly, procaine inhibits Ca# + -activated Cl − currents elicited by LPA in Xenopus oocytes [39] .
A third intracellular Ca# + -release pathway, which involves sphingolipids, has recently been described [40] [41] [42] [43] , and although the pathway remains to be fully elucidated, a novel intracellular sphingolipid-gated Ca# + -channel (termed SCaMPER) has been cloned [44] . Furthermore, agonists acting on GPCRs have been shown to stimulate Ca# + mobilization through the production of SPP [29] , an action that occurs via the enzyme sphingosine kinase. In the present study, DMS, a competitive inhibitor of sphingosine kinase [45] , almost completely blocked the Ca# + response to a supramaximal application of LPA and approximately halved the peak Ca# + response to MCh. This was not a non-specific effect of sphingolipids, as the related compounds NAS and dihydro-NAS were without effect. Similarly, the effect of DMS was not due to an emptying of the intracellular Ca# + store, as there was no significant reduction in the ionomycinsensitive Ca# + pool. Although the competitive nature of the DMS inhibition makes interpreting these findings more complicated, the results suggest that both LPA and MCh utilize the production of SPP, although to different extents. Thus LPA, which does not stimulate Ins(1,4,5)P $ production in SH-SY5Y cells, may release Ca# + solely by increasing intracellular SPP. In contrast, MCh, which produces a robust Ins(1,4,5)P $ response, is only partially sensitive to DMS, and so may be able to utilize dual pathways leading to Ca# + release. Previously, muscarinic M # -and M $ -receptors transfected into HEK-293 cells have been shown to mobilize Ca# + through the production of intracellular SPP [29] , and so this may be a common pathway for this receptor type, although in HEK-293 cells M # -and M $ -receptors also stimulate Ins(1,4,5)P $ production. Importantly, in HEK-293 cells, DMS did not alter muscarinic receptor-induced InsP accumulation, or the ability of Ins(1,4,5)P $ to release Ca# + directly [29] , indicating that DMS did not interfere with the phosphoinositide signalling pathway. Similarly in SH-SY5Y cells, DMS did not inhibit MCh-induced InsP production (results not shown).
The actions of LPA in SH-SY5Y cells may therefore prove to be a useful model for investigating the role of sphingosine kinase activation in Ca# + -mobilizing responses, without the additional Ins(1,4,5)P $ -sensitive component that is present with other GPCRs. That the LPA response involves a GPCR is strongly suggested by the sensitivity of LPA-mediated Ca# + signalling, in permeabilized SH-SY5Y cells, to GDP [S] . The lack of effect of PTX pretreatment excludes an involvement of G i -proteins and distinguishes responses observed in the present study from those mediated by the phosphoinositide-linked recombinant Edg-2 and Edg-4 receptors. LPA has recently been shown to be a lowaffinity agonist for the cell surface SPP-receptor, Edg-1 [46] . However, in the present study it is unlikely that LPA-responses occurred via this receptor, as Edg-1 effects are also G i -mediated [47] , and extracellular SPP itself only produces a small Ca# + response in intact SH-SY5Y cells. The Ca# + response to LPA was inhibited by short-term pretreament with phorbol 12,13-dibutyrate, suggesting some involvement of protein kinase C. Inhibition of GPCR-mediated responses by phorbol ester treatment has been reported previously [48] , and may indicate that phosphorylation of the LPA receptor attenuates signalling. However, effects on elements downstream of receptor activation cannot be excluded. In addition, the lack of effect of the kinase inhibitors bisindoylmaleimide, H-89 and genistein on LPA-induced Ca# + mobilization indicates that it is unlikely that the LPA-receptor utilizes activation of C-, A-or tyrosine-kinases in the Ca# + response. The observation that extracellular SPP itself produces a modest increase in [Ca# + ] i is interesting, as it suggests that this bioactive lipid may have both intracellular and extracellular signalling effects [49] . What is also apparent from this study is that emptying the LPA-, and hence sphingolipid-, sensitive intracellular Ca# + pool stimulates the process of store-refilling-mediated Ca# + entry, as indicated by Mn# + quenching. This would appear to differentiate the LPA response in SH-SY5Y cells from the nonInsP $ R-, non-RyR-mediated effects of LPA in Jurkat T-cells [7] . Perhaps the most remarkable feature of LPA-mediated Ca# + mobilization in SH-SY5Y cells is that, despite the involvement of different signalling pathways, increases in [Ca# + ] i are almost indistinguishable from those stimulated in these cells by MCh. Thus, without recruiting either InsP $ Rs or RyRs, LPA can trigger a Ca# + increase which is similar in magnitude to, and only marginally slower than, that stimulated by MCh. Furthermore, the similarities between Ca# + -release responses to LPA and MCh suggest that the production of SPP, if indeed this proves to be the LPA-stimulated pathway, may be of equal significance in Ca# + -mobilization responses to the more established Ins(1,4,5)P $ pathway. It will be of interest therefore to determine the relative abilities of LPA and MCh to stimulate SPP production in SH-SY5Y cells. Such studies are presently underway in this laboratory. In the light of the present study, however, the action of LPA in SH-SY5Y cells may prove to be a valuable means of investigating non-Ins(1,4,5)P $ -mediated Ca# + signalling.
